Skip to content

Clinical trials

Multiple Sclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: United Kingdom Clear all

235 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20027
20031
20044
20051
20068
200713
200812
20099
20105
20119
20129
201315
201413
20159
20168
201712
201813
201911
202012
202114
202214
20239
202410
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed152
Terminated22
Unknown status21
Active, not recruiting17
Recruiting15
Enrolling by invitation3
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen26
Jazz Pharmaceuticals13
Sanofi11
Novartis Pharmaceuticals10
Queen Mary University of London9
University of Nottingham9
Hoffmann-La Roche8
Genzyme, a Sanofi Company7
Novartis6
Actelion5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis235
Multiple Sclerosis, Relapsing-Remitting30
Multiple Sclerosis, Chronic Progressive13
Muscle Spasticity11
Recurrence10
Fatigue7
Pain7
Stroke7
Optic Neuritis6
Parkinson Disease5

Trials

Showing 1 to 25 of 235. Each trial links to its page on Pharma Observatory.

135 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.